Transversus Abdominis Plane Block Compared to Local Anesthetic Wound Infiltration in Gynecologic Oncology Surgery

Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexFemale
Age18+
SponsorUniversity of Wisconsin, Madison

About this trial

This study is being done to see if preoperative transversus abdominis plane (TAP) analgesia will provide similar postoperative pain control, hospital length of stay, and postoperative outcomes compared to surgeon-initiated wound infiltration with local anesthetic in participants undergoing laparotomy for gynecologic indications.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Ability to understand and the willingness to sign a written informed consent document

Patients undergoing exploratory laparotomy via midline vertical skin incision for gynecologic indications at UW Hospital and Clinics

Patients must be >18 years old

English speaking (able to provide consent and complete questionnaires)

Disqualifiers

Known allergy to local anesthetics.

Known history of chronic pain disorders and/or chronic opioid use defined as greater than 10mg of PO morphine or equivalent used daily for at least 30 days prior to enrollment.

Patient has a history of opioid dependence requiring rehabilitation or the use of opioid antagonists.

Patients with a planned exploration with biopsies (no organs removed) will be excluded from the study.

Trial design

Design model

Parallel

Treatments tested in this trial

  • TAP Anesthesia

    Drug

    ultrasound guided TAP block, 133 mg of liposomal bupivacaine and 15 mL of 0.25% bupivacaine deposited into the TAP on each side for a total of two injections

  • Surgeon-Initiated Local Anesthetic

    Drug

    266 mg of liposomal bupivacaine and 30 mL of 0.25% bupivacaine diluted in 130 mL of normal saline (160 mL of solution), 40 mL fascial injection and 40 mL skin injection on either side of the wound

Treatment groups

80 Participants
are divided into 2 treatment groups
Group A: TAP Block plus LaparotomyActive comparator 1 intervention
Group B: Laparotomy plus Local Wound AnestheticActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Total opioid use measured in oral morphine equivalents for the first 24 hours post-surgery

Total opioid use measured in oral morphine equivalents for the first 24 hours post-surgery (including intraoperative and Post Anesthesia Care Unit (PACU) opioid utilization).

Time frame
24 hours post-surgery

Secondary outcomes

1

Mean postoperative pain score for the first 24 hours post-surgery

Mean postoperative pain score for the first 24 hours post-surgery, measured by the Numeric Rating Scale (NRS), which rates pain on a 0-10 scale (collected routinely on the post-operative floor). Higher numbers indicate worse pain.

Time frame
24 hours post-surgery
2

Length of hospital stay, measured in whole hours from admission to PACU to time of discharge order placement

Time frame
estimated to be up to 3 days
3

Post-operative anti-emetic use

A study team member will review the patient's medical chart to record the number of times an anti-emetic was given to the subject.

Time frame
estimated to be up to 3 days
4

Number of recorded episodes of emesis

A study team member will review the patient's medical chart to record number of times the hospital staff observed a participant vomit.

Time frame
estimated to be up to 3 days

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.